MeiraGTx
MGTX
S$10.39
Share price
-1.94%
Change (1 day)
57.38%
Change (1 year)
Earnings for MeiraGTx (MGTX)
Earnings in 2025 (TTM): -S$0.21 Billion
According to MeiraGTx's latest financial reports the company's current earnings are S$34.5 Million. In 2024 the company made an earning of -S$0.18 Billion a decrease over its 2023 earnings that were of -S$91.14 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for MeiraGTx from 2017 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -S$0.21 Billion | 19.06% |
| 2024 | -S$0.18 Billion | 90.05% |
| 2023 | -S$91.14 Million | -43.22% |
| 2022 | -S$0.17 Billion | 57.27% |
| 2021 | -S$0.11 Billion | 37.02% |
| 2020 | -S$74.49 Million | 5.77% |
| 2019 | -S$70.43 Million | -34.34% |
| 2018 | -S$0.11 Billion | 168.72% |
| 2017 | -S$39.92 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | -S$0.16 Billion | -24.05% | Jersey |
 Novavax NVAX | S$0.65 B | -430.73% | 🇺🇸 USA |
 Organovo ONVO | -S$3.21 Million | -98.39% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -S$94.07 Million | -52.64% | 🇬🇧 UK |